Clinical Chemistry
News on clinical chemistry systems and applications.
At the ADLM annual meeting, firms said they see game-changing opportunities for platforms that provide the right combination of clinical utility and convenience.
Roche Diagnostics Base Business Grows 9 Percent in First Half of 2024, Firm Raises FY24 Outlook
The firm's overall sales were nearly flat year over year, although at constant exchange rates sales increased 5 percent.
The firm discussed further reducing its headcount as well as increasing its molecular and lab instrument menu as a path to margin restoration.
Roche to Acquire LumiraDx Point-of-Care Testing Tech for up to $350M
Roche expects to integrate the POC clinical chemistry and immunoassay tests into its Diagnostics business when the acquisition closes in mid-2024.
Revenues for Roche Diagnostics totaled CHF 3.33 billion in Q3, with the base business up 7 percent, excluding COVID-19-related testing.